Chong Kun Dang Pharmaceutical
185750.KO
49.25 USD
0.41
+0.84%
c
Overview
Last close
49.25 usd
Market cap
648.88M usd
52 week high
69.35 usd
52 week low
41.76 usd
Target price
76.17 usd
Valuation
P/E
10.8095
Forward P/E
N/A
Price/Sales
0.4819
Price/Book Value
0.8421
Enterprise Value
713.36M usd
EV/Revenue
0.5403
EV/EBITDA
7.3779
Key financials
Revenue TTM
1.32B usd
Gross Profit TTM
393.28M usd
EBITDA TTM
91.05M usd
Earnings per Share
4.47 usd
Dividend
0.37 usd
Total assets
1.21B usd
Net debt
152.52M usd
About
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
- Symbol185750.KO
- ExchangeKO
- IsinKR7185750007
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Young-Joo Kim
- HeadquarterSeoul
- Web sitehttps://www.ckdpharm.com
Related indices
Related news
November 18
JAKOTA Stocks on November 17, 2023 